Use of prescription drug samples and patient assistance programs, and the role of doctor-patient communication

Journal of General Internal Medicine

Volumn 26, Issue 12, 2011, Pages 1458-1464

  Gellad, Walid F ^a,b,c   Huskamp, Haiden A ^d   Li, Angela ^e,f   Zhang, Yuting ^g   Safran, Dana Gelb ^e,f   Donohue, Julie M ^g  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c RAND CORPORATION   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f Blue Cross Blue Shield of Massachusetts   (United States)

^g UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

free drug samples; Medicare; physician patient communication; prescription assistance programs

Indexed keywords

AGED; ARTICLE; DOCTOR PATIENT RELATION; DRUG INDUSTRY; DRUG MARKETING; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH PROGRAM; HEALTH STATUS; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRESCRIPTION; QUESTIONNAIRE;

AGED; AGED, 80 AND OVER; COMMUNICATION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEDICAL ASSISTANCE; MEDICARE; PHYSICIAN-PATIENT RELATIONS; PRESCRIPTION DRUGS; PRESCRIPTION FEES; UNITED STATES;

EID: 83655201450     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-011-1801-y     Document Type: Article

References (40)

1. P Neuman MK Strollo S Guterman, et al. 2007 Medicare Prescription Drug Benefit Progress Report: Findings From A 2006 National Survey Of Seniors Health Aff 26 5 w630 w643 10.1377/hlthaff.26.5.w630
2. JD Piette M Heisler TH Wagner 2004 Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk Am J Public Health 94 10 1782 1787 15451750 10.2105/AJPH.94.10.1782
3. JD Piette M Heisler TH Wagner 2004 Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med 164 16 1749 1755 15364667 10.1001/archinte.164.16.1749
4. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff (Millwood). 2005;Suppl Web Exclusives:W5-152-W155-166.
5. SB Soumerai M Pierre-Jacques F Zhang, et al. 2006 Cost-related medication nonadherence among elderly and disabled Medicare beneficiaries: a national survey 1 year before the Medicare drug benefit Arch Intern Med 166 17 1829 1835 17000938 10.1001/archinte.166.17.1829
6. JM Madden AJ Graves D Ross-Degnan BA Briesacher SB Soumerai 2009 Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007 JAMA 302 16 1755 1756 19861666 10.1001/jama.2009.1516 1:CAS:528:DC%2BD1MXhtlGku7rN
7. Y Zhang JM Donohue JP Newhouse JR Lave 2009 The effects of the coverage gap on drug spending: a closer look at Medicare Part D Health Aff (Millwood) 28 2 w317 w325 10.1377/hlthaff.28.2.w317
8. Zhang Y, Lave JR, Newhouse JP, Donohue JM. How the Medicare part D drug benefit changed the distribution of out-of-pocket pharmacy spending among older beneficiaries. J Gerontol B Psychol Sci Soc Sci. 2009.
9. K Zivin JM Madden AJ Graves F Zhang SB Soumerai 2009 Cost-related medication nonadherence among beneficiaries with depression following Medicare Part D Am J Geriatr Psychiatry 17 12 1068 1076 20104063 10.1097/JGP. 0b013e3181b972d1
10. S Chimonas JP Kassirer 2009 No more free drug samples? PLoS Med 6 5 e1000074 19434227 10.1371/journal.pmed.1000074
11. SL Cutrona S Woolhandler KE Lasser, et al. 2008 Free drug samples in the United States: characteristics of pediatric recipients and safety concerns Pediatrics 122 4 736 742 18829796 10.1542/peds.2007-2928
12. SL Cutrona S Woolhandler KE Lasser DH Bor D McCormick DU Himmelstein 2008 Characteristics of recipients of free prescription drug samples: a nationally representative analysis Am J Public Health 98 2 284 289 18172135 10.2105/AJPH.2007.114249
13. J Whittle CB Good 2008 Prescription drug samples: making decisions with imperfect data J Gen Intern Med 23 6 890 892 18461406 10.1007/s11606-008-0642-9
14. GC Alexander J Zhang A Basu 2008 Characteristics of patients receiving pharmaceutical samples and association between sample receipt and out-of-pocket prescription costs Med Care 46 4 394 402 18362819 10.1097/MLR.0b013e3181618ee0
15. JT Chen KH Summers 2007 Pharmaceutical manufacturer prescription assistance programs: are they worth it? J Manag Care Pharm 13 7 611 613 17874869
16. MA Chisholm JT DiPiro 2002 Pharmaceutical manufacturer assistance programs Arch Intern Med 162 7 780 784 11926851 10.1001/archinte.162.7.780
17. LR Van Diepen 2001 Pharmaceutical manufacturer assistance programs for indigent patients: solution or symptom? Am J Health Syst Pharm 58 2 162 163 11202541
18. D Chauncey CD Mullins BV Tran D McNally RN McEwan 2006 Medication access through patient assistance programs Am J Health Syst Pharm 63 13 1254 1259 16790577 10.2146/ajhp050457
19. NK Choudhry JL Lee J Agnew-Blais C Corcoran WH Shrank 2009 Patient Assistance Programs: Information Is Not Our Enemy Health Aff 28 3 843 844 10.1377/hlthaff.28.3.843
20. NK Choudhry JL Lee J Agnew-Blais C Corcoran WH Shrank 2009 Drug Company-Sponsored Patient Assistance Programs: A Viable Safety Net? Health Aff 28 3 827 834 10.1377/hlthaff.28.3.827
21. GC Alexander LP Casalino DO Meltzer 2005 Physician strategies to reduce patients' out-of-pocket prescription costs Arch Intern Med 165 6 633 636 15795338 10.1001/archinte.165.6.633
22. IB Wilson C Schoen P Neuman, et al. 2007 Physician-patient communication about prescription medication nonadherence: a 50-state study of America's seniors J Gen Intern Med 22 1 6 12 17351835 10.1007/s11606-006-0093-0
23. DG Safran MK Strollo S Guterman A Li WH Rogers P Neuman 2010 Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study J Gen Intern Med 25 1 10 17 19882193 10.1007/s11606-009-1134-2
24. Buck S. A method of estimation of missing values in multivariate data suitable for use with an electronic computer. J R Stat Soc. 1960;22(2):302-306.
25. J Tjia BA Briesacher SB Soumerai D Ross-Degnan JH Gurwitz 2008 Medicare beneficiaries and free prescription drug samples: a national survey J Gen Intern Med 23 10 1727 10.1007/s11606-008-0745-3
26. DA Taira KA Iwane RS Chung 2003 Prescription drugs: elderly enrollee reports of financial access, receipt of free samples, and discussion of generic equivalents related to type of coverage Am J Manag Care 9 4 305 312 12703674
27. K Johnson 2009 Voluntary Patient Assistance Programs: Additional Federal Oversight Unwarranted Health Aff 28 3 835 838 10.1377/hlthaff.28.3.835
28. RG Pinckney AS Helminski AG Kennedy CD Maclean L Hurowitz E Cote 2011 The effect of medication samples on self-reported prescribing practices: a statewide, cross-sectional survey J Gen Intern Med 26 1 40 44 20809157 10.1007/s11606-010-1483-x
29. RF Adair LR Holmgren 2005 Do drug samples influence resident prescribing behavior? A randomized trial Am J Med 118 8 881 884 16084181 10.1016/j.amjmed.2005.02.031
30. LD Chew TS O'Young TK Hazlet KA Bradley C Maynard DS Lessler 2000 A physician survey of the effect of drug sample availability on physicians' behavior J Gen Intern Med 15 7 478 483 10940134 10.1046/j.1525-1497.2000.08014.x 1:STN:280:DC%2BD3cvivFGrsQ%3D%3D
31. Morgan W, Mihaly C, Van Tassel-Sweet AJ. Report of the Vermont Attorney General on the Advisability of Requiring Disclosure of Free Samples Distributed by Manufacturers of Prescribed Products to Vermont Health Care Providers January 15, 2010. Available at http://www.atg.state.vt.us/assets/files/ Free%20Samples%20Report.pdf (Accessed June 2011).
32. Institute of Medicine of the National Academies. Conflict of Interest in Medical Research, Education and Practice 2009.
33. Medicare Payment Advisory Commission. Report to Congress, Medicare Payment Policy. 2009:332-35.
34. Partnership for Prescription Assistance (PPA). By the Numbers: PPA Impact, http://www.pparx.org/en/about-us/ppa-impact. Accessed February 10, 2010.
35. U.S. Department of Health and Human Services Office of Inspector General. Special Advisory Bulletin on Patient Assistance Programs for Medicare Part D Enrollees: Federal Register. Vol 70.; 2005:70623-628.
36. WH Shrank T Hoang SL Ettner, et al. 2006 The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions Arch Intern Med 166 3 332 337 16476874 10.1001/archinte.166.3.332
37. MS Beran M Laouri M Suttorp R Brook 2007 Medication costs: the role physicians play with their senior patients J Am Geriatr Soc 55 1 102 107 17233692 10.1111/j.1532-5415.2006.01011.x
38. B Sleath D Roter B Chewning B Svarstad 1999 Asking questions about medication: analysis of physician-patient interactions and physician perceptions Med Care 37 11 1169 1173 10549619 10.1097/00005650-199911000-00009 1:STN:280:DC%2BD3c%2FhsFyisA%3D%3D
39. DM Tarn DA Paterniti J Heritage RD Hays RL Kravitz NS Wenger 2006 Physician communication about the cost and acquisition of newly prescribed medications Am J Manag Care 12 11 657 664 17090222
40. Kaiser Family Foundation. Medicare Fact Sheet: The Medicare Prescription Drug Benefit. November 2006. http://www.kff.org/medicare/upload/7044-05.pdf. Accessed February 1, 2011.